Cellid, Co., Ltd. (KOSDAQ: A299660)
Health Care · Biotechnology · KR
₩2,300.00
-8.18% today · -35.3% 1Y
Cellid, Co., Ltd. (KOSDAQ: A299660) operates in the Biotechnology industry within the Health Care sector. The company is valued at $50.90M.
Over the last twelve months the share price has lost 35.3%, trading between 973.00 and 4.76K.
Tweenvest scores Cellid, Co., Ltd. across four factors: quality 55/100, value 49/100. Its strongest factor is quality.
A299660 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $50.90M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 1.36
- 52-week high
- ₩4,760.00
- 52-week low
- ₩973.00
- Avg volume (3M)
- —
- Shares outstanding
- 29.50M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Prestige BioPharma LimitedKOSE: A950210 | $51.30M | ₩5,690.00 | -4.53% |
| Nano Holdings, Inc.TSE: 4571 | $51.13M | ¥89.00 | +12.66% |
| Uni-Bio Science Group LimitedSEHK: 690 | $50.98M | HK$0.07 | -4.29% |
| Rein Therapeutics Inc.NasdaqCM: RNTX | $50.92M | $0.59 | -25.65% |
| FluoGuide A/SOM: FLUO | $50.52M | Skr30.60 | -3.47% |
| Naturalendo Tech Co., Ltd.KOSDAQ: A168330 | $50.32M | ₩2,125.00 | -11.09% |
| Kidswell Bio CorporationTSE: 4584 | $50.31M | ¥157.00 | -1.88% |
| Elicio Therapeutics, Inc.NasdaqCM: ELTX | $49.94M | $1.90 | -2.06% |
Figures last refreshed Oct 18, 2026.